Application Requirements
The Astellas Access ProgramSM (AAP) provides stock replacement of injectable/infused medications that have been administered to eligible, uninsured patients who meet program guidelines. The number of product units administered to the patient will be sent to the provider's office or hospital, at no cost to the healthcare provider.
The following information is required for each individual application for stock replacement.
| Provider Information | Patient Information |
|
|
To request support, the healthcare provider should access Astellas eService and provide the required information for the Astellas Access ProgramSM. The application must be submitted to the Astellas Access ProgramSM within 180 days of the date of service for the last injection or infusion.
If the application is approved, you will receive replacement of the number of product units that were administered to the patient.
